Back to LXRX

Artal Group S.A. → LXRX

Artal Group S.A. LXRX Position History

Lexicon Pharmaceuticals, Inc.

Quarters held
4
Latest value
$329.3M
Q3 2026
Peak value
$420.4M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$156.6M
Q1 2026$241.4M
Q2 2026$420.4M
Q3 2026$329.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$329.3M175.16M——
Q2 2026$420.4M175.16M——
Q1 2026$241.4M154.73M——
Q4 2025$156.6M136.18M——

Other funds holding LXRX

Other Artal Group S.A. positions

CAVA

Cava Group Inc

$769.2M
CAVA

Cava Group Inc

$558M
CAVA

Cava Group Inc

$510.7M
CAVA

Cava Group Inc

$352.1M
IQMXW

IQM Quantum Computers Oyj

$5.2M